Article Information
History
- June 26, 2020.
Article Versions
- Version 1 (June 18, 2020 - 03:54).
- Version 2 (June 23, 2020 - 12:42).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Petra Mlcochova1,2,*,
- Dami Collier*,1,2,3,
- Allyson Ritchie4,
- Sonny M. Assennato4,
- Myra Hosmillo5,
- Neha Goel4,
- Bo Meng1,2,
- Krishna Chatterjee6,
- Vivien Mendoza6,
- Nigel Temperton7,
- Leo Kiss8,
- Leo C. James8,
- Katarzyna A. Ciazynska8,
- Xiaoli Xiong8,
- John AG Briggs8,
- James Nathan1,2,
- Federica Mescia1,2,
- Hongyi Zhang9,
- Petros Barmpounakis10,
- Nikos Demeris10,11,
- Richard Skells6,11,
- Paul A. Lyons1,2,
- John Bradley3,12,
- Steven Baker1,2,
- Jean Pierre Allain4,
- Kenneth GC Smith1,2,
- Ian Goodfellow5 and
- Ravindra K. Gupta1,2,13,#
- 1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
- 2Department of Medicine, University of Cambridge, Cambridge, UK
- 3Division of Infection and Immunity, University College London, UK. WC1E 6BT
- 4Diagnostics for the Real World EU Ltd., Chesterford Research Park, UK
- 5Department of Pathology, University of Cambridge, Cambridge
- 6NIHR Cambridge Clinical Research Facility, Cambridge, UK
- 7Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, UK
- 8Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
- 9Clinical Microbiology & Public Health Laboratory, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
- 10Department of Statistics, Athens University of Economics and Business, Athens, Greece
- 11Cambridge Clinical Trials Unit-Cancer Theme
- 12National Institutes for Health Research Cambridge Biomedical Research Centre, Cambridge, UK
- 13Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
- 14Africa Health Research Institute, Durban, South Africa
- ↵#Address for correspondence: Ravindra K. Gupta, Cambridge Institute for Therapeutic Immunology and Infectious Diseases Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus Puddicombe Way, Cambridge CB2 0AW, Tel: +44 1223 331491, rkg20{at}cam.ac.uk
↵* Equal contribution